Holen Sie sich die Stockscreener-App
1.31
0.76%
-0.01
Handel nachbörslich:
1.32
0.01
+0.76%
Vivos Therapeutics Inc Aktie (VVOS) Neueste Nachrichten
Broadcom, Vivos Therapeutics And 3 Stocks To Watch Heading Into Monday - Benzinga
Vivos Therapeutics Enters Securities Purchase Agreement with V-CO Investors 3 LLC and Issues New Warrants – Form 8-K Filing Details - Minichart
VVOS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
If You Invested $1,000 in Vivos Therapeutics Inc (VVOS) - Stock Titan
Vivos Therapeutics Completes Private Placement to Bolster Liquidity - TipRanks
Vivos Therapeutics Secures $0.85M PIPE, Converts $1.4M Bridge Note With Seneca Affiliate - TradingView
Vivos Therapeutics (NASDAQ: VVOS) gets $850,000 PIPE cash plus $1,400,000 bridge note conversion - Stock Titan
Why Did Vivos Therapeutics (VVOS) Stock Jump Over 21% After Hours - Sahm
VVOS | Vivos Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
Vivos Therapeutics investor V-Co investors 3 LLC buys shares worth $1.8m By Investing.com - investing.com
Vivos Therapeutics (NASDAQ: VVOS) investor buys stock, pre-funded warrants - Stock Titan
Michael C. Skaff Discloses Investment at Vivos Therapeutics with 19.9% Stake - TradingView
Investor group (NASDAQ: VVOS) funds Vivos with $2.39M PIPE and warrants - Stock Titan
VVOS Technical Analysis & Stock Price Forecast - Intellectia AI
Vivos Therapeutics Delays Annual Filing Amid Expansion - TipRanks
Vivos Therapeutics’ Supported Practices Achieve In-Network Status in Nevada - Sleep Review
Vivos Therapeutics (NASDAQ: VVOS) delays 2025 Form 10-K, cites SCN acquisition - Stock Titan
Buyback Watch: What are Vivos Therapeutics Incs earnings expectations2026 Recap & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Vivos Therapeutics, Inc. announced that it has received $2.389957 million in funding from V-Co Investors 3 LLC - marketscreener.com
Vivos Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Earnings Risk: Can Vivos Therapeutics Inc withstand a market correction2026 Drop Watch & Breakout Confirmation Alerts - baoquankhu1.vn
Vivos Therapeutics Inc (referred to as Vivos Therapeutics) recently disclosed a comprehensive cost optimization strategy. - Bitget
Vivos Therapeutics gains Nevada insurance network access By Investing.com - Investing.com Canada
Vivos Therapeutics gains Nevada insurance network access - Investing.com
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market - The Manila Times
Vivos Therapeutics Announces In-Network Insurance Coverage for OSA Treatments in Nevada and Initiates Cost Reduction Measures - Quiver Quantitative
More Las Vegas sleep apnea patients gain coverage as Vivos cuts costs - Stock Titan
Aug Swings: Will Vivos Therapeutics Inc benefit from government policy2026 Top Gainers & Community Shared Stock Ideas - baoquankhu1.vn
Decliners Report: Is Vivos Therapeutics Inc in a long term uptrend2026 Fundamental Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
SoundHealth Partners With Vivos Therapeutics to Expand Sleep Tech Access - Medical Product Outsourcing
Vivos Therapeutics (VVOS) to Release Quarterly Earnings on Monday - Defense World
Is Vivos Therapeutics Inc part of any ETFQuarterly Portfolio Report & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Vivos Therapeutics, Inc. Study Affirms Link Between Dental Morphology and Obstructive Sleep Apnea Severity - Quiver Quantitative
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy - GlobeNewswire
Aug Breakouts: Is Vivos Therapeutics Inc part of any ETFFed Meeting & Weekly Top Performers Watchlists - baoquankhu1.vn
Winners Losers: Will Vivos Therapeutics Inc benefit from government policyWeekly Stock Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Bearish Setup: Is Vivos Therapeutics Inc part of any ETF2025 Technical Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - ACCESS Newswire
VVOS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Aug Sentiment: Can Vivos Therapeutics Inc maintain its current growth rateChart Signals & Low Drawdown Momentum Ideas - baoquankhu1.vn
Vivos Therapeutics (NASDAQ:VVOS) Stock Price Down 6.7% – Here’s What Happened - Defense World
CEO Moves: What are Complete Solaria Inc Equity Warrants recent SEC filings showingJuly 2025 Technicals & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
What dividend growth rate does Vivos Therapeutics Inc. offerProduct Launch & Low Drawdown Trading Strategies - mfd.ru
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST) - facilitiesmanagement-now.com
What are Vivos Therapeutics Inc.’s earnings expectationsIPO Watch & Free High Return Stock Watch Alerts - mfd.ru
VVOS Financials: Income Statement, Balance Sheet & Cash Flow | Vivos Therapeutics Inc - Stock Titan
Retail Surge: Can Vivos Therapeutics Inc maintain its current growth rate2025 Valuation Update & Real-Time Buy Signal Notifications - baoquankhu1.vn
Is Vivos Therapeutics Inc. showing insider buying2025 Price Targets & Verified Swing Trading Watchlists - mfd.ru
VIX Spike: How does Vivos Therapeutics Inc score in quality rankingsEarnings Growth Report & Expert Curated Trade Setups - baoquankhu1.vn
Will Vivos Therapeutics Inc. benefit from government policyDollar Strength & Weekly Top Stock Performers List - mfd.ru
Gap Down: Is Vivos Therapeutics Inc part of any ETF2025 Technical Overview & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Can Vivos Therapeutics Inc. stock hit record highs againJuly 2025 Analyst Calls & High Conviction Buy Zone Alerts - mfd.ru
Earnings Update: How correlated is Vivos Therapeutics Inc to the S P5002025 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn
Vivos Therapeutics Appoints Gregg Johnson to Board - The Globe and Mail
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):